Article Text
Editorial commentary
Quality of life in motor neurone disease—towards a more practical assessment tool?
Statistics from Altmetric.com
Footnotes
-
Competing interests: JDM and MRO’B have received support and honoraria from pharmaceutical companies involved in the development of drugs for the treatment of MND.